Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jacob Kattoula"'
Autor:
Richard Childers, Ben Liotta, Jesse Brennan, Phoebe Wang, Jacob Kattoula, Thien Tran, Henry Montilla-Guedez, Edward M. Castillo, Gary Vilke
Publikováno v:
Heliyon, Vol 8, Iss 10, Pp e11049- (2022)
Background: Exposing patients with a low probability of disease to diagnostic testing with poor test characteristics leads to false positive results. Providers often act on these false results, which can cause unnecessary evaluation and treatment. Th
Externí odkaz:
https://doaj.org/article/f68ba90fab4548088b3d3357c5f6dd6a
Autor:
Ittipat Meewan, Jacob Kattoula, Julius Y. Kattoula, Danielle Skinner, Pavla Fajtová, Miriam A. Giardini, Brendon Woodworth, James H. McKerrow, Jair Lage de Siqueira-Neto, Anthony J. O’Donoghue, Ruben Abagyan
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 744 (2022)
One inhibitor of the main SARS-CoV-2 protease has been approved recently by the FDA, yet it targets only SARS-CoV-2 main protease (Mpro). Here, we discovered inhibitors containing thiuram disulfide or dithiobis-(thioformate) tested against three key
Externí odkaz:
https://doaj.org/article/657345c2310e45a7868c20618d38774e
Autor:
Miriam A. Giardini, Pavla Fajtová, Jair L. Siqueira-Neto, Julius Y. Kattoula, Jacob Kattoula, Brendon Woodworth, Anthony J. O’Donoghue, Ruben Abagyan, Ittipat Meewan, James H. McKerrow, Danielle E. Skinner
There are currently no FDA approved inhibitors of SARS-CoV-2 viral proteases with specific treatment for post-exposure of SARS-CoV-2. Here, we discovered inhibitors containing thiuram disulfide or dithiobis-(thioformate) tested against three key prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6136bd851ab68b98475f4d3da0d5744c
https://doi.org/10.1101/2021.10.19.465036
https://doi.org/10.1101/2021.10.19.465036
